These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6613840)

  • 21. Dangerous interaction between amiodarone and quinidine.
    Tartini R; Kappenberger L; Steinbrunn W; Meyer UA
    Lancet; 1982 Jun; 1(8285):1327-9. PubMed ID: 6123639
    [No Abstract]   [Full Text] [Related]  

  • 22. Insidiously evolving, occult drug interaction involving warfarin and amiodarone.
    Cheung B; Lam FM; Kumana CR
    BMJ; 1996 Jan; 312(7023):107-8. PubMed ID: 8555895
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous amiodarone in the treatment of refractory arrhythmias.
    Alves LE; Rose EP; Cahill TB
    Crit Care Med; 1985 Sep; 13(9):750-2. PubMed ID: 4028770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using oral amiodarone safely.
    Drug Ther Bull; 2003 Feb; 41(2):9-12. PubMed ID: 12630334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone: A Comprehensive Guide for Clinicians.
    Hamilton D; Nandkeolyar S; Lan H; Desai P; Evans J; Hauschild C; Choksi D; Abudayyeh I; Contractor T; Hilliard A
    Am J Cardiovasc Drugs; 2020 Dec; 20(6):549-558. PubMed ID: 32166725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone.
    Med Lett Drugs Ther; 1986 May; 28(713):49-50. PubMed ID: 3702807
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amiodarone in the long-term treatment of arrhythmia].
    Trusz-Gluza M; Giec L; Kośmider J; Strzelczyk B
    Wiad Lek; 1984 Nov; 37(22):1753-7. PubMed ID: 6531902
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
    Goldschlager N; Epstein AE; Naccarelli G; Olshansky B; Singh B
    Arch Intern Med; 2000 Jun; 160(12):1741-8. PubMed ID: 10871966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
    Hoffmann A; Follath F; Burckhardt D
    Lancet; 1983 Mar; 1(8326 Pt 1):704-5. PubMed ID: 6132058
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.
    Tsikouris JP; White CM; Kluger J
    Conn Med; 2000 Jan; 64(1):35-8. PubMed ID: 10697362
    [No Abstract]   [Full Text] [Related]  

  • 34. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
    Kuo CS; Reddy CP; Paciotti MV
    J Electrocardiol; 1985 Jan; 18(1):105-9. PubMed ID: 3882871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous amiodarone in the treatment of supraventricular arrhythmias: immediate results].
    César LA; Ping WC; Miyasato AN; Mansur A; Rossi E; Yamano J; Choui AF; Carneiro L; Bellotti GM; Pileggi FJ
    Arq Bras Cardiol; 1982 Jun; 38(6):495-8. PubMed ID: 7168680
    [No Abstract]   [Full Text] [Related]  

  • 37. Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.
    Ghembaza Mel A; Lounici A
    Indian J Gastroenterol; 2016 Jul; 35(4):319-20. PubMed ID: 27481353
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
    Marcus FI; Fontaine GH; Frank R; Grosgogeat Y
    Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of Cordarone].
    Preobrazhenskiĭ DV; Ryndina MG; Blizniak GV
    Kardiologiia; 1979 Apr; 19(4):107-12. PubMed ID: 35642
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical efficacy of intravenous amiodarone in the treatment of cardiac arrhythmia].
    Tao P
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):1-4, 61. PubMed ID: 6525897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.